KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to 17.55%.

  • Zimmer Biomet Holdings' EBITDA Margin rose 22300.0% to 17.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.63%, marking a year-over-year increase of 1700.0%. This contributed to the annual value of 16.74% for FY2024, which is 5400.0% down from last year.
  • According to the latest figures from Q3 2025, Zimmer Biomet Holdings' EBITDA Margin is 17.55%, which was up 22300.0% from 14.44% recorded in Q2 2025.
  • In the past 5 years, Zimmer Biomet Holdings' EBITDA Margin registered a high of 19.23% during Q4 2024, and its lowest value of 1.55% during Q4 2022.
  • Moreover, its 5-year median value for EBITDA Margin was 15.31% (2025), whereas its average is 14.46%.
  • Data for Zimmer Biomet Holdings' EBITDA Margin shows a peak YoY increase of 417200bps (in 2021) and a maximum YoY decrease of -122100bps (in 2021) over the last 5 years.
  • Zimmer Biomet Holdings' EBITDA Margin (Quarter) stood at 7.53% in 2021, then plummeted by -121bps to 1.55% in 2022, then surged by 1277bps to 18.26% in 2023, then increased by 5bps to 19.23% in 2024, then fell by -9bps to 17.55% in 2025.
  • Its EBITDA Margin was 17.55% in Q3 2025, compared to 14.44% in Q2 2025 and 15.31% in Q1 2025.